ArticleInternational journal of endocrinology2025
Thyroid-Stimulating Hormone Regulates the Glucose Metabolism in Hepatocytes via Toll-Like Receptor 4/Tollip Pathway.
Article in International journal of endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Interorgan Crosstalk in MASLD: A Narrative Review.Biomedicines · 2026Review
- With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.Hepatology (Baltimore, Md.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic disorders are closely associated with thyroid dysfunction and the activity of thyroid-stimulating hormone (TSH). Previously, we found that subclinical hypothyroidism aggravates Toll-like receptor 4 (TLR4) signaling and interferes with glucose metabolism in rat liver tissue. Here, we explored the underlying mechanisms by which TSH affected TLR4 and glucose metabolism on hepatocytes in vitro. Hepatocytes were stimulated with TSH (0, 5, 10, and 20 mIU/mL) for 12 h and mRNA level of its receptor, thyroid-stimulating hormone receptor (TSHR), was increased. In contrast, glucose metabolism was blocked. After blocking TSHR, glucose metabolism in hepatocytes was rescued. Additionally, TSH treatment also activated TLRs signaling, and the expression of TLR4 and its downstream partners all decreased after TSHR was silenced, which indicated that TSH promotes TLR4 signaling through a TSHR-dependent mechanism. For the exploitation of the underlying relationship between TLR4 and glucose metabolism, siRNA was utilized to silence TLR4. After silencing TLR4, glucose metabolism was significantly rescued, which indicated that TLR4 was involved in the TSH-mediated downregulation of glucose metabolism in hepatocytes. Furthermore, as for the inhibitor of TLRs, Tollip was also measured. Under TSH treatment, the expression level of Tollip decreases. After silencing Tollip, TLR4 and its partners significantly increased and glucose metabolism was reduced. Our study indicated that TSH/TSHR regulated hepatocellular glucose metabolism via the TLR4/Tollip pathway.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.